(Access to Coverage of Tobacco Treatment In Our Nation)
Shaping Policies | Improving Health
April 2, 2011 In combating the tobacco epidemic, the U.S. Food and Drug Administration has released two separate draft guidance documents designed to help implement provisions of the Family Smoking Prevention and Tobacco Control Act. In one case, the FDA wants to provide consumers with previously unknown information about harmful and potentially harmful constituents in tobacco products. HPHCs are chemicals in tobacco products that either cause or could cause harm to smokers or nonsmokers. In the other case, the FDA wants to prevent misleading marketing of modified-risk tobacco products. MRTPs are tobacco products that are distributed, marketed, or sold with claims that they cut either the harm or the risk of tobacco-related disease.
Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.
All Content © ActionToQuit. All Rights Reserved